CAMG
TAK icon

CWA Asset Management Group’s Takeda Pharmaceutical TAK Stock Holding History

CWA Asset Management Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,421
Closed -$258K – 377
2023
Q2 		$258K Buy
+16,421
New +$269K 0.02% 306

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWA Asset Management Group's TAK Position: Q3 2023 in Review

CWA Asset Management Group sold out of Takeda Pharmaceutical (TAK) in Q3 2023, closing a stake of 16,421 shares — an estimated $258K sold.

CWA Asset Management Group first reported a position in TAK in Q2 2023 and held it in 1 quarter. The position peaked at $258K in Q2 2023. 312 funds tracked by Wall St. Rank hold TAK as of Q3 2023.

  • CWA Asset Management Group reported no remaining Takeda Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • CWA Asset Management Group sold 16,421 Takeda Pharmaceutical shares in Q3 2023, an estimated $258K.
  • CWA Asset Management Group first reported a position in Takeda Pharmaceutical in Q2 2023 and held it in 1 quarter.
  • CWA Asset Management Group's Takeda Pharmaceutical position peaked at $258K in Q2 2023.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2023.

Based on CWA Asset Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.